MBRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Moleculin Biotech Inc (MBRX).


$5.10M Market Cap.

As of 03/21/2025 5:00 PM ET (MRY) • Disclaimer

MBRX Market Cap. (MRY)


MBRX Shares Outstanding (MRY)


MBRX Assets (MRY)


Total Assets

$16.93M

Total Liabilities

$10.95M

Total Investments

$0

MBRX Income (MRY)


Revenue

$0

Net Income

-$21.76M

Operating Expense

$26.64M

MBRX Cash Flow (MRY)


CF Operations

-$23.86M

CF Investing

-$13.00K

CF Financing

$4.63M

MBRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MBRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$16,925,000 (-55.71%)

$38,217,000 (-33.45%)

$57,422,000 (-31.71%)

$84,090,000 (189.66%)

Assets Current

$5,194,000 (-80.23%)

$26,273,000 (-42.38%)

$45,596,000 (-37.11%)

$72,497,000 (321.54%)

Assets Non-Current

$11,731,000 (-1.78%)

$11,944,000 (1.00%)

$11,826,000 (2.01%)

$11,593,000 (-2.03%)

Goodwill & Intangible Assets

$11,148,000 (0.00%)

$11,148,000 (0.00%)

$11,148,000 (0.00%)

$11,148,000 (0.00%)

Shareholders Equity

$5,979,000 (-77.07%)

$26,073,000 (-50.04%)

$52,191,000 (-33.93%)

$78,993,000 (344.78%)

Property Plant & Equipment Net

$583,000 (-26.76%)

$796,000 (17.40%)

$678,000 (52.36%)

$445,000 (-35.04%)

Cash & Equivalents

$4,278,000 (-81.83%)

$23,550,000 (-45.42%)

$43,145,000 (-39.15%)

$70,903,000 (367.30%)

Accumulated Other Comprehensive Income

-$41,000 (-355.56%)

-$9,000 (-175.00%)

$12,000 (-70.73%)

$41,000 (-36.92%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,030,000 (-18.73%)

$2,498,000 (19.24%)

$2,095,000 (53.59%)

$1,364,000 (20.81%)

Accumulated Retained Earnings (Deficit)

-$153,367,000 (-16.54%)

-$131,604,000 (-29.23%)

-$101,835,000 (-39.86%)

-$72,810,000 (-27.93%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$358,000 (-24.47%)

$474,000 (41.49%)

$335,000 (431.75%)

$63,000 (-60.38%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$358,000 (-24.47%)

$474,000 (41.49%)

$335,000 (431.75%)

$63,000 (-60.38%)

Total Liabilities

$10,946,000 (-9.86%)

$12,144,000 (132.15%)

$5,231,000 (2.63%)

$5,097,000 (-54.78%)

Liabilities Current

$5,359,000 (-21.36%)

$6,815,000 (41.42%)

$4,819,000 (33.05%)

$3,622,000 (24.04%)

Liabilities Non-Current

$5,587,000 (4.84%)

$5,329,000 (1193.45%)

$412,000 (-72.07%)

$1,475,000 (-82.34%)

MBRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$8,786,000 (-12.29%)

$10,017,000 (-13.21%)

$11,542,000 (37.63%)

$8,386,000 (23.60%)

Research & Development Expense

$17,729,000 (-9.02%)

$19,487,000 (2.74%)

$18,968,000 (31.56%)

$14,418,000 (13.02%)

Operating Expenses

$26,641,000 (-10.09%)

$29,631,000 (-3.29%)

$30,640,000 (33.40%)

$22,968,000 (16.34%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$21,763,000 (26.89%)

-$29,769,000 (-2.56%)

-$29,025,000 (-82.62%)

-$15,894,000 (8.42%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$21,763,000 (26.89%)

-$29,769,000 (-2.56%)

-$29,025,000 (-82.62%)

-$15,894,000 (8.42%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$21,763,000 (26.89%)

-$29,769,000 (-2.56%)

-$29,025,000 (-82.62%)

-$15,894,000 (8.42%)

Weighted Average Shares

$3,442,997 (74.28%)

$1,975,610 (-93.09%)

$28,604,397 (6.43%)

$26,875,927 (172.97%)

Weighted Average Shares Diluted

$3,442,997 (74.28%)

$1,975,610 (-93.09%)

$28,604,397 (6.43%)

$26,875,927 (172.97%)

Earning Before Interest & Taxes (EBIT)

-$21,763,000 (26.89%)

-$29,769,000 (-2.56%)

-$29,025,000 (-82.62%)

-$15,894,000 (8.42%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$26,641,000 (10.09%)

-$29,631,000 (3.29%)

-$30,640,000 (-33.40%)

-$22,968,000 (-16.34%)

MBRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$13,000 (89.52%)

-$124,000 (-85.07%)

-$67,000 (-252.63%)

-$19,000 (94.92%)

Net Cash Flow from Financing

$4,635,000 (-0.34%)

$4,651,000 (20321.74%)

-$23,000 (-100.03%)

$74,724,000 (231.38%)

Net Cash Flow from Operations

-$23,862,000 (0.99%)

-$24,101,000 (12.80%)

-$27,639,000 (-45.84%)

-$18,951,000 (-6.64%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$19,272,000 (1.65%)

-$19,595,000 (29.41%)

-$27,758,000 (-149.81%)

$55,730,000 (1155.75%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$13,000 (89.52%)

-$124,000 (-85.07%)

-$67,000 (-252.63%)

-$19,000 (94.92%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$4,661,000 (11.88%)

$4,166,000 (0%)

$0 (0%)

$74,747,000 (231.24%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$32,000 (-52.38%)

-$21,000 (27.59%)

-$29,000 (-20.83%)

-$24,000 (-170.59%)

Share Based Compensation

$1,726,000 (-13.00%)

$1,984,000 (-12.79%)

$2,275,000 (-4.13%)

$2,373,000 (41.25%)

Depreciation Amortization & Accretion

$126,000 (-0.79%)

$127,000 (-2.31%)

$130,000 (-20.73%)

$164,000 (-18.00%)

MBRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-165.00% (-103.96%)

-80.90% (-73.98%)

-46.50% (-143.46%)

-19.10% (82.62%)

Return on Average Assets (ROAA)

-90.00% (-32.94%)

-67.70% (-60.43%)

-42.20% (-142.53%)

-17.40% (71.66%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

898.10% (-47.50%)

1710.60% (19.61%)

1430.20% (17.18%)

1220.50% (-92.42%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.27 (68.50%)

-0.85 (18.67%)

-1.05 (66.70%)

-3.15 (-16.05%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.85 (-12.95%)

0.98 (68.85%)

0.58 (-13.67%)

0.67 (-76.00%)

Debt to Equity Ratio (D/E)

1.83 (292.92%)

0.47 (366.00%)

0.1 (53.85%)

0.07 (-89.76%)

Earnings Per Share (EPS)

-6.32 (58.06%)

-15.07 (-1392.08%)

-1.01 (-71.19%)

-0.59 (66.48%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-6.93 (43.45%)

-12.26 (-1165.43%)

-0.97 (-37.25%)

-0.71 (61.69%)

Book Value Per Share (BVPS)

1.74 (-86.84%)

13.2 (623.12%)

1.82 (-37.90%)

2.94 (62.92%)

Tangible Assets Book Value Per Share (TABVPS)

1.68 (-87.75%)

13.7 (746.85%)

1.62 (-40.38%)

2.71 (49.45%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

1 (0.00%)

1 (150.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.18 (454.90%)

-0.05 (-107.49%)

0.68 (-51.18%)

1.4 (164.35%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.97 (-74.86%)

3.85 (-59.26%)

9.46 (-52.73%)

20.02 (239.83%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$23,875,000 (1.44%)

-$24,225,000 (12.56%)

-$27,706,000 (-46.05%)

-$18,970,000 (-4.55%)

Enterprise Value (EV)

-$3,911,778 (-359.70%)

$1,506,284 (107.65%)

-$19,681,503 (10.33%)

-$21,949,616 (-159.03%)

Earnings Before Tax (EBT)

-$21,763,000 (26.89%)

-$29,769,000 (-2.56%)

-$29,025,000 (-82.62%)

-$15,894,000 (8.42%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$21,637,000 (27.01%)

-$29,642,000 (-2.59%)

-$28,895,000 (-83.69%)

-$15,730,000 (8.31%)

Invested Capital

-$3,502,000 (-24.10%)

-$2,822,000 (-108.27%)

-$1,355,000 (10.86%)

-$1,520,000 (-2880.39%)

Working Capital

-$165,000 (-100.85%)

$19,458,000 (-52.28%)

$40,777,000 (-40.80%)

$68,875,000 (382.39%)

Tangible Asset Value

$5,777,000 (-78.66%)

$27,069,000 (-41.50%)

$46,274,000 (-36.56%)

$72,942,000 (307.88%)

Market Capitalization

$5,103,222 (-80.06%)

$25,589,284 (-15.67%)

$30,345,497 (-42.91%)

$53,153,384 (6.75%)

Average Equity

$13,187,500 (-64.16%)

$36,790,750 (-41.05%)

$62,408,000 (-25.14%)

$83,367,000 (428.07%)

Average Assets

$24,184,750 (-45.01%)

$43,979,250 (-36.00%)

$68,712,500 (-24.93%)

$91,527,500 (223.91%)

Invested Capital Average

-$2,423,250 (-39.25%)

-$1,740,250 (14.25%)

-$2,029,500 (-55.85%)

-$1,302,250 (-1108.58%)

Shares

3,001,895 (51.05%)

1,987,363 (-93.06%)

28,627,827 (0.18%)

28,577,088 (174.50%)